Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ibrahim, Laniyan"'
Autor:
Michael A. Smith, Christine A. Clarke, Ibrahim Laniyan, Paulette Furbert-Harris, William Green, Theresa R. Vaughn, Debra Parish-Gause
Publikováno v:
Journal of Cancer Therapy. :482-492
Prostate cancer is the second leading cause of cancer deaths in the United States and remains a significant health concern for men throughout the world. Despite the discovery of promising immunotherapeutic strategies, curative outcomes remain elusive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50768b809e84b51ad69fbf0000481d79
https://doi.org/10.4236/jct.2015.66052
https://doi.org/10.4236/jct.2015.66052
Autor:
Oladipo A. Oredipe, Rajagopalan Sridhar, Paulette Furbert-Harris, Walter M. Griffin, Ibrahim Laniyan
Publikováno v:
International Immunopharmacology. 3:1537-1547
The limits of stimulation of the immunomodulatory alkaloid swainsonine (8alphabeta-indolizidine-1alpha,2alpha,8beta-triol) were studied in inbred C57BL/6 mice for potential support of intense high dose cancer chemotherapy and/or radiation because of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29176a03756ef5fbad9e9afd5ae2d28
https://doi.org/10.1016/s1567-5769(03)00186-3
https://doi.org/10.1016/s1567-5769(03)00186-3
Autor:
Ibrahim Laniyan, Josephine Okomo-Awich, Debra Parish-Gause, Keith A. Hunter, Oladipo A. Oredipe, Paulette Furbert-Harris, Theresa R. Vaughn, Kesha C. Forrest, Abier Abdelnaby, Christina Howland
Publikováno v:
The Prostate. 57:165-175
BACKGROUND Host Immune response to prostate cancer primarily involves the CTL and NK effector cells. Recent immunotherapeutic strategies incorporating cytokine genes into the tumor cell and/or dendritic cells have had encouraging results. In this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbf9b48c31f44313007190f3fb77393
https://doi.org/10.1002/pros.10286
https://doi.org/10.1002/pros.10286
Autor:
William Green, Debra Parish-Gause, Paulette Furbert-Harris, Sandra L. White, Walter M. Griffin, Oladipo A. Oredipe, Ibrahim Laniyan, Kenneth Olden, Rajagopalan Sridhar, Theresa R. Vaughn
Publikováno v:
International Immunopharmacology. 3:445-455
The immunomodulatory alkaloid swainsonine (8alphabeta-indolizidine-1alpha,2alpha,8beta-triol) has potential for overcoming the bone marrow suppressive effects of cancer chemotherapy and radiotherapy. An earlier study showed that multiple doses of swa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0bf903dce484e64dfb334cc3707d381
https://doi.org/10.1016/s1567-5769(03)00042-0
https://doi.org/10.1016/s1567-5769(03)00042-0
Autor:
Paulette Furbert-Harris, William Green, Theresa R. Vaughn, Walter M. Griffin, Rajagopalan Sridhar, Debra Parish-Gause, Sandra L. White, Ibrahim Laniyan, Oladipo A. Oredipe, Kenneth Olden
Publikováno v:
Pharmacological Research. 47:69-74
The immunomodulatory alkaloid swainsonine (8alphabeta-indolizidine-1alpha,2alpha,8beta-triol) has potential for overcoming the bone marrow suppressive effects of cancer chemotherapeutic drugs and radiation. The effect of swainsonine on bone marrow ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37c7a54915220e75d3fdf70bf89bbee
https://doi.org/10.1016/s1043-6618(02)00254-2
https://doi.org/10.1016/s1043-6618(02)00254-2
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 24:A83-A83
Introduction: Despite the discovery of promising anti-cancer immunotherapeutic strategies such as cancer vaccines, cytokines, and T cell-based therapies, curative outcomes remain elusive. We have investigated the eosinophil as a potential anti-cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d2ae223e06465c7ea0a11c3fd3ed8aa
https://doi.org/10.1158/1538-7755.disp14-a83
https://doi.org/10.1158/1538-7755.disp14-a83
Autor:
Elizabeth B, Fryar, Jharna R, Das, Jillian H, Davis, Joseph A, Desoto, Ibrahim, Laniyan, William M, Southerland, Donnell, Bowen
Publikováno v:
Anticancer research. 26(3A)
The selective estrogen receptor modulator raloxifene (RAL), used to treat and prevent osteoporosis, is under investigation for its use in the treatment and prevention of breast cancer. RAL in combination with the antimetabolites methotrexate (MTX) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc7f05972f4ed018576df67a0b598ed3
https://pubmed.ncbi.nlm.nih.gov/16827118
https://pubmed.ncbi.nlm.nih.gov/16827118
Autor:
Paulette M, Furbert-Harris, Ibrahim, Laniyan, Dana, Harris, Georgia M, Dunston, Theresa, Vaughn, Abier, Abdelnaby, Debra, Parish-Gause, Oladipo A, Oredipe
Publikováno v:
Anticancer research. 23(1A)
Previous studies in our laboratory have shown that activated eosinophils and eosinophilic cell lines inhibit the in vitro growth of MCF-7 breast tumor cells. We have also shown that IL-4 and IL-5 partially inhibit MCF-7 growth in vitro. In this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6b08e354127a281e56e1f12a9bf5c286
https://pubmed.ncbi.nlm.nih.gov/12680196
https://pubmed.ncbi.nlm.nih.gov/12680196
Autor:
Theresa R. Vaughn, Debra Parish-Gause, Oladipo A. Oredipe, Ibrahim Laniyan, Paulette Furbert-Harris
Publikováno v:
Human Immunology. 70:S152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a33a37583b082b0f344f526c4e84e7ed
https://doi.org/10.1016/j.humimm.2009.09.312
https://doi.org/10.1016/j.humimm.2009.09.312
Autor:
Theresa R. Vaughn, Charles N. Rotimi, Paulette M Furburt-Harris, Debra P Gause, Ibrahim Laniyan, Georgia M. Dunston, Gary L Ellison
Publikováno v:
Diabetes Research and Clinical Practice. 50:160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8a808112f78956de060737f09522517
https://doi.org/10.1016/s0168-8227(00)82001-x
https://doi.org/10.1016/s0168-8227(00)82001-x